- Eagle Pharmaceuticals (NASDAQ:EGRX): Q3 Non-GAAP EPS of $1.17 beats by $0.88; GAAP EPS of $0.51 beats by $0.49.
- Revenue of $49.93M (+21.3% Y/Y) beats by $2.95M.
- Press Release
- https://seekingalpha.com/news/3629493-eagle-pharmaceuticals-eps-beats-0_88-beats-on-revenue
Monday, November 2, 2020
Eagle Pharmaceuticals EPS beats by $0.88, beats on revenue
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.